跳至主要内容
临床试验/CTRI/2022/01/039113
CTRI/2022/01/039113已完成未知

Randomized controlled study to evaluate efficacy of dexamethasone versus prednisolone in induction phase in pediatric and adolescent acute lymphoblastic leukemia with respect to day 33 bone marrow minimal residual disease response

All India Institute of Medical Sciences Rishikesh0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed patients of acute lymphoblastic leukemia (both B-ALL & T-ALL), between 1 year to 24 years of age, of any gender, where informed consent of parent/guardian is available

排除标准

  • 1.Infantile acute lymphoblastic leukemia (age < 1 year).
  • 2.Patients of lymphoblastic lymphoma (LBL).
  • 3.Relapsed cases of acute lymphoblastic leukemia.
  • 4.Patients who have received dexamethasone, prednisolone or any other chemotherapy within 4 weeks of enrollment in study

研究者

相似试验